Skip to main content

MoneyWorks4Me

Net sales declined -11.11%  to  Rs. 131.42 million from Rs. 147.84 millions.The Company's Net profit for the September 2026 quarter have declined marginally to Rs. 4.17  millions as against Rs. 5.04 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 19.33 millions from 18.21 millions in the quarter ended September 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 131.42 147.84 -11.11 318.20 319.34 -0.36 589.07 559.79 5.23
Other Income 0.97 0.56 73.21 0.98 0.78 25.64 3.88 1.76 120.45
PBIDT 19.33 18.21 6.15 49.19 49.70 -1.03 71.19 91.40 -22.11
Interest 4.37 5.27 -17.08 9.78 12.89 -24.13 23.68 20.66 14.62
PBDT 14.96 12.94 15.61 39.41 36.81 7.06 47.51 70.74 -32.84
Depreciation 9.67 9.02 7.21 19.25 17.84 7.90 36.20 35.60 1.69
PBT 5.29 3.92 34.95 20.16 18.97 6.27 11.31 35.14 -67.81
TAX 1.12 -1.12 -200.00 4.92 2.70 82.22 2.79 9.04 -69.14
Deferred Tax -0.18 -2.12 -91.51 -0.10 -2.05 -95.12 0.39 -4.55 -108.57
PAT 4.17 5.04 -17.26 15.24 16.27 -6.33 8.52 26.10 -67.36
Equity 54.85 54.85 0.00 54.85 54.85 0.00 54.85 54.85 0.00
PBIDTM(%) 14.71 12.32 19.41 15.46 15.56 -0.67 12.09 16.33 -25.98
Peers
Company Name CMP
Sun Pharma. Inds. 1776.00
Dr. Reddys Labs. 1372.00
Cipla 1400.10
Lupin 2015.00
Zydus Lifesciences 1190.00
View more..